<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, to the best of our knowledge, the present study is first to integrate PCGs and lncRNAs to predict tumor recurrence in patients with NFPA. The current study may provide novel insights into prognostic evaluation and help patients benefit from early intervention.</p>
